Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2006-05-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistant Starch on Glucose and Insulin Sensitivity in Individuals With Type 2 Diabetes
NCT00691249
Effect of Resistant Starch Type 4 on Glycemia and Insulin Sensitivity in Young Adults
NCT00687960
Resistant Starch on Glycemic Response in Older Adults
NCT00676767
Food Containing Resistant Starch Type 4 and Postprandial Glycemic Response
NCT03844503
Effects of Resistant Starch in a Baked Snack Bar on a Post-prandial Glycemic and Insulinemic Response
NCT02187913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the morning of each test, a finger-prick capillary blood samples will be collected to determine fasting (baseline) blood glucose levels. The volunteers will then consume the test solution assigned for that trial. Ten minutes will be allowed for the test solution to be consumed. Over the two hours following the start of each test, finger-prick capillary blood samples were collected at 30, 60, 90, and 120 min. Blood glucose levels will be immediately measured in duplicate using an automated blood glucose analyzer (YSI 2300, Yellow Springs, OH). Analysis of the collected sample was repeated if the difference between duplicate samples was greater than 0.1 mmol/L. Once the samples were analyzed, the data was entered and the incremental area under the curve was calculated using the trapezoidal model (GraphPad v5.0, La Jolla, CA).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dextrose
30 g of carbohydrate via Sun-Dex OGTT beverage
Resistant Starch
30 g of carbohydrate per Arm
RS Type 2
30g Resistant Starch Type 2 (Hi-Maize 260, National Starch)
Resistant Starch
30 g of carbohydrate per Arm
RS Type 4 (cross linked)
30g of cross linked RS type 4 (Fibersym RW, MGP Ingredients, Inc.)
Resistant Starch
30 g of carbohydrate per Arm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistant Starch
30 g of carbohydrate per Arm
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* wheat allergy
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kansas State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kansas State University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark D Haub, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Kansas State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Metabolism Laboratory (K-State Univ.)
Manhattan, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSUHML09-RS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.